Dialysis and Renal Disease Management
Dialysis and Renal Disease Management is a research topic within Nephrology. Science Explorer counts 51k research works in it since 1950. 15.0% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on chronic kidney disease, dialysis treatment, and associated complications such as inflammation, cardiovascular disease, and malnutrition. It explores the impact of dialysis dose, intradialytic hypotension, uremic toxins, and the role of nutrition in improving outcomes and quality of life for patients. The cluster also addresses the epidemiology of kidney disease and mortality risk factors in hemodialysis and peritoneal dialysis patients.
- Dialysis
- Chronic Kidney Disease
- Inflammation
- Mortality
- Hemodialysis
- Peritoneal Dialysis
- Cardiovascular Disease
- Nutrition
- Uremic Toxins
- Quality of Life
- Research works
- 51k fractional, since 1950
- In the world top 10%
- 7.7k per year above
- Top-10% rate
- 15.0% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +30% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Dialysis and Renal Disease Management research?
By volume, the United States and China publish the most (1.9k and 1.6k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.9k works
- 2 China 1.6k works
- 3 Japan 550 works
- 4 Brazil 444 works
- 5 India 436 works
- 6 United Kingdom 433 works
- 7 Spain 316 works
- 8 Canada 280 works
- 9 Italy 275 works
- 10 Türkiye 272 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Dialysis and Renal Disease Management research?
By volume in 2022–2025, Ain Shams University publishes the most Dialysis and Renal Disease Management research, followed by Sichuan University and Aristotle University of Thessaloniki.
By volume, 2022–2025
- 1 Ain Shams UniversityEgypt 39 works
- 2 Sichuan UniversityChina 29 works
- 3 Aristotle University of ThessalonikiGreece 28 works
- 4 University of North Carolina at Chapel HillUnited States 28 works
- 5 Johns Hopkins UniversityUnited States 28 works
- 6 Sun Yat-sen UniversityChina 28 works
- 7 Karolinska InstitutetSweden 26 works
- 8 Fresenius Medical Care (Germany)Germany 26 works
- 9 Fresenius Medical Care (United States)United States 25 works
- 10 Stanford UniversityUnited States 25 works
Who are the leading researchers in Dialysis and Renal Disease Management?
The most-cited researchers publishing on Dialysis and Renal Disease Management include Giuseppe Remuzzi, Juan Jesús Carrero and Marcello Tonelli.
- 1 Giuseppe Remuzzi Italy 8.1k citations
- 2 Juan Jesús Carrero Sweden 6.5k citations
- 3 Marcello Tonelli Canada 5.9k citations
- 4 Alberto Ortíz Spain 5.9k citations
- 5 Vivekanand Jha India 5.8k citations
- 6 Josef Coresh United States 5.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Dialysis and Renal Disease Management research done?
The largest centres of Dialysis and Renal Disease Management research in 2022–2025 are Beijing (China), Tokyo (Japan), Guangzhou (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bad Homburg and Waltham.
Largest cities, 2022–2025
Where it is the local speciality
- Bad HomburgDE · 32.2 works136×
- WalthamUS · 42.5 works21×
Location quotient: how much more of its research is in Dialysis and Renal Disease Management than the world average.
Where is the best place to study Dialysis and Renal Disease Management?
Among universities, judged by research, Karolinska Institutet, Southern Medical University and Guangzhou University of Chinese Medicine score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Karolinska InstitutetSweden | 59.4 | 23.7% | 6.0× | 26 | +9.1% |
| 2 | Southern Medical UniversityChina | 55.2 | 25.5% | 4.8× | 17 | +169.5% |
| 3 | Guangzhou University of Chinese MedicineChina | 53.1 | 30.9% | 6.8× | 12 | — |
| 4 | Sichuan UniversityChina | 52.7 | 26.4% | 1.7× | 29 | +143.5% |
| 5 | Aristotle University of ThessalonikiGreece | 52.2 | 6.4% | 5.6× | 28 | +207.8% |
| 6 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 52.2 | 27.5% | 1.9× | 18 | +225.4% |
| 7 | University of LeicesterUnited Kingdom | 51.7 | 20.1% | 4.9× | 11 | +232.5% |
| 8 | Tianjin Medical UniversityChina | 50.5 | 30.0% | 4.3× | 8 | +305.7% |
| 9 | Ain Shams UniversityEgypt | 49.5 | 1.5% | 5.5× | 39 | +171.6% |
| 10 | Soochow UniversityChina | 48.5 | 29.6% | 1.8× | 14 | +169.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Dialysis and Renal Disease Management research growing?
Output in 2018–2022 was 30% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Dialysis and Renal Disease Management.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.